{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:22:34Z","timestamp":1789734154148,"version":"4.0.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OTT"],"DOI":"10.2147\/ott.s39987","type":"journal-article","created":{"date-parts":[[2013,4,26]],"date-time":"2013-04-26T05:05:34Z","timestamp":1366952734000},"page":"471","source":"Crossref","is-referenced-by-count":17,"title":["A review of the use of somatostatin analogs in oncology"],"prefix":"10.2147","author":[{"given":"Suayib","family":"Yalcin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Keskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,4]]},"container-title":["OncoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=15930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:19:41Z","timestamp":1477865981000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/a-review-of-the-use-of-somatostatin-analogs-in-oncology-peer-reviewed-article-OTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ott.s39987","relation":{},"ISSN":["1178-6930"],"issn-type":[{"value":"1178-6930","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}